These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 26031759

  • 1. Killer immunoglobulin receptor genes and their HLA-C ligand are associated with Type 1 diabetes in an Eastern Indian population.
    Sanjeevi S, Sun C, Kanungo A, Sanjeevi CB.
    Diabet Med; 2016 Jan; 33(1):91-6. PubMed ID: 26031759
    [Abstract] [Full Text] [Related]

  • 2. Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.
    Shastry A, Sedimbi SK, Rajalingam R, Nikitina-Zake L, Rumba I, Wigzell H, Sanjeevi CB.
    Int J Immunogenet; 2008 Dec; 35(6):439-46. PubMed ID: 19046302
    [Abstract] [Full Text] [Related]

  • 3. Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.
    Shastry A, Sedimbi SK, Rajalingam R, Rumba I, Kanungo A, Sanjeevi CB.
    Ann N Y Acad Sci; 2008 Dec; 1150():133-8. PubMed ID: 19120281
    [Abstract] [Full Text] [Related]

  • 4. Killer cell immunoglobulin-like receptor along with HLA-C ligand genes are associated with type 1 diabetes in Chinese Han population.
    Zhi D, Sun C, Sedimbi SK, Luo F, Shen S, Sanjeevi CB.
    Diabetes Metab Res Rev; 2011 Nov; 27(8):872-7. PubMed ID: 22069276
    [Abstract] [Full Text] [Related]

  • 5. The investigation of killer cell immunoglobulin-like receptor genotyping in patients with systemic lupus erytematosus and systemic sclerosis.
    Tozkır JD, Tozkır H, Gürkan H, Dönmez S, Eker D, Pamuk GE, Pamuk ÖN.
    Clin Rheumatol; 2016 Apr; 35(4):919-25. PubMed ID: 26960450
    [Abstract] [Full Text] [Related]

  • 6. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.
    Giebel S, Boratyn-Nowicka A, Karabon L, Jedynak A, Pamula-Pilat J, Tecza K, Kula D, Kowal M, Frydecka I, Grzybowska E.
    Hum Immunol; 2014 Jun; 75(6):508-13. PubMed ID: 24755350
    [Abstract] [Full Text] [Related]

  • 7. Significant association of the KIR2DL3/HLA-C1 genotype with susceptibility to Crohn's disease.
    Díaz-Peña R, Vidal-Castiñeira JR, Moro-García MA, Alonso-Arias R, Castro-Santos P.
    Hum Immunol; 2016 Jan; 77(1):104-109. PubMed ID: 26542067
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Genetic risk for co-occurrence of type 1 diabetes and celiac disease is modified by HLA-C and killer immunoglobulin-like receptors.
    Smigoc Schweiger D, Mendez A, Kunilo Jamnik S, Bratanic N, Bratina N, Battelino T, Brecelj J, Vidan-Jeras B.
    Tissue Antigens; 2014 Nov; 84(5):471-8. PubMed ID: 25329633
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Investigation of activating and inhibitory killer cell immunoglobulin-like receptors and their putative ligands in type 1 diabetes (T1D).
    Osman AE, Eltayeb-ELSheikh N, Mubasher M, Al Harthi H, Alharbi S, Hamza MA, ElGhazali G.
    Hum Immunol; 2016 Jan; 77(1):110-114. PubMed ID: 26542066
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Quantity of HLA-C surface expression and licensing of KIR2DL+ natural killer cells.
    Charoudeh HN, Schmied L, Gonzalez A, Terszowski G, Czaja K, Schmitter K, Infanti L, Buser A, Stern M.
    Immunogenetics; 2012 Oct; 64(10):739-45. PubMed ID: 22772778
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.
    Gao X, Jiao Y, Wang L, Liu X, Sun W, Cui B, Chen Z, Zhao Y.
    Clin Immunol; 2010 Oct; 137(1):139-46. PubMed ID: 20643584
    [Abstract] [Full Text] [Related]

  • 17. The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression.
    Kandilarova SM, Paschen A, Mihaylova A, Ivanova M, Schadendorf D, Naumova E.
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):73-81. PubMed ID: 28083606
    [Abstract] [Full Text] [Related]

  • 18. Association of the genetic diversity of killer cell immunoglobulin-like receptor genes and HLA-C ligand in Saudi women with breast cancer.
    Alomar SY, Alkhuriji A, Trayhyrn P, Alhetheel A, Al-Jurayyan A, Mansour L.
    Immunogenetics; 2017 Feb; 69(2):69-76. PubMed ID: 27631728
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke.
    Tuttolomondo A, Di Raimondo D, Pecoraro R, Casuccio A, Di Bona D, Aiello A, Accardi G, Arnao V, Clemente G, Corte VD, Maida C, Simonetta I, Caruso C, Squatrito R, Pinto A, KIRIIND (KIR Infectious and Inflammatory Diseases) Collaborative Group.
    J Neuroinflammation; 2019 Apr 17; 16(1):88. PubMed ID: 30995924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.